Purchase Order HHSN272201500352P
Award Date 2/3/15
Potential Completion Date 3/1/15
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $5,805.81, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of a "GENE-TO-PROTEIN PACKAGE, PFC1045C" and has an ultimate completion date of March 4, 2011. Genscript USA Inc. is a for-profit organization that...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $6,965.30, is for the production of customized protein production in a baculovirus expression system. The award does not have a set-aside designation. Genscript USA Inc. has received numerous prime and subcontract...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....
- This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $12,714.08, is for customized protein expression and plasmid preparation services. This award is not a set-aside contract. The contract supports research activities at NIAID, which is the lead NIH institute...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $9,062.13 firm fixed-price purchase order is for plasmid and recombinant protein expression services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has a history of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This federal contract award, valued at $5,091.65, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for gene synthesis services and does not have a set-aside designation. Genscript USA Inc. is a well-established provider of molecular biology products and services to various federal agencies, including the National...
- This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide custom-produced biotinylated and non-biotinylated proteins. The $45,035.54 contract supports the mission of the Vaccine Research Center, which had previously used Genscript's proteins in downstream experiments. The contract has no set-aside designation. Genscript, based in Piscataway,...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...